No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
(GKOS) - Analyzing Glaukos's Short Interest
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target
Glaukos Seeks FDA Approval for Non-Invasive Keratoconus Therapy Epioxa
Price Over Earnings Overview: Merit Medical Systems
Hims & Hers Health Are Falling Today: What's Going On?
FDA Clarifies Policies For Compounders As National GLP-1 Supply Begins To Stabilize; Does Not Intend To Take Action Against Compounders For Violations Of FD&C Act Arising From Conditions That Depend On Tirzepatide Injection